Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention

Interstitial lung diseases comprise a heterogenous range of diffuse lung disorders, potentially resulting in pulmonary fibrosis. While idiopathic pulmonary fibrosis has been recognized as the paradigm of a progressive fibrosing interstitial lung disease, other conditions with a progressive fibrosing...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Vito D’Agnano, Domenica Francesca Mariniello, Michela Ruotolo, Gianluca Quarcio, Alessandro Moriello, Stefano Conte, Antonio Sorrentino, Stefano Sanduzzi Zamparelli, Andrea Bianco, Fabio Perrotta
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2024-02-01
Serija:	Life
Teme:	progressive pulmonary fibrosis biomarkers antifibrotics nintedanib pirfenidone
Online dostop:	https://www.mdpi.com/2075-1729/14/2/229
Oznake:	Označite Brez oznak, prvi označite!